Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference

Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference

The annual ImmunoRad Conference has established itself as a recurrent occasion to explore the possibility of combining radiation therapy (RT) and immunotherapy (IT) for clinical cancer management. Bringing together a number of preclinical and clinical leaders in the fields of radiation oncology, imm...

Full description

Saved in:
Bibliographic Details
Main Authors: Fereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, Nir Ben Chetrit, Brian D. Brown, Timothy A. Chan, Dhan Chand, Julie Constanzo, Sandra Demaria, Dmitry I. Gabrilovich, Encouse Golden, Andrew Godkin, Chandan Guha, Gaorav P. Gupta, Aisha Hasan, Fernanda G. Herrera, Howard Kaufman, Donna Li, Alan A. Melcher, Sierra McDonald, Taha Merghoub, Arta M. Monjazeb, Sébastien Paris, Sean Pitroda, Anguraj Sadanandam, Dörthe Schaue, Laura Santambrogio, Phillippe Szapary, Julien Sage, James W. Welsh, Anna Wilkins, Kristina H. Young, Eric Wennerberg, Laurence Zitvogel, Lorenzo Galluzzi, Eric Deutsch, Silvia C. Formenti
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:OncoImmunology
Subjects:
Abscopal effect
CAR T cells
CD8+ cytotoxic T lymphocytes
low-dose radiation therapy
TREG cells
tumor-associated macrophages
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2025.2507856
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The annual ImmunoRad Conference has established itself as a recurrent occasion to explore the possibility of combining radiation therapy (RT) and immunotherapy (IT) for clinical cancer management. Bringing together a number of preclinical and clinical leaders in the fields of radiation oncology, immuno-oncology and IT, this annual event fosters indeed essential conversations and fruitful exchanges on how to address existing challenges to expand the therapeutic value of RT-IT combinations. The 8th edition of the ImmunoRad Conference, which has been held in October 2024 at the Weill Cornell Medical College of New York City, highlighted exciting preclinical and clinical advances at the interface between RT and IT, setting the stage for extra progress toward extended benefits for patients with an increasing variety of tumor types. Here, we critically summarize the lines of investigation that have been discussed at the occasion of the 8th Annual ImmunoRad Conference.
ISSN:2162-402X

Similar Items